CU Medical Systems, Inc (115480) Fair Value & Analysis
Healthcare · KR · Market cap 23.6B KRW
Fair value as of: Jul 7, 2026
From 24 valuation models · updated today
Fair value updated Jul 7, 2026 — revised from 8,193 KRW to 1,134 KRW (−86.2%) since Jun 24, 2026. Share price +2.1% over the past month.
Price vs Fair Value (12 months)
12‑month range 1,804 KRW – 3,220 KRW · fair‑value band 850.60 KRW – 1,418 KRW · the 1,904 KRW price screens above the 1,134 KRW fair value. As of Jul 7, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
CU Medical Systems, Inc (115480) currently trades at 1,904 KRW, while our model-based Fair Value estimate is 1,134 KRW — implying the stock looks roughly 40.4% overvalued today. We read business quality at 60/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, CU Medical Systems, Inc generated revenue of 45.0B KRW at a net margin of -6.5%. Revenue grew 56.9% year over year. Net debt stands at 13.7B KRW. Fundamentals as of Jul 7, 2026
Our scenario range runs from 850.60 KRW (bear case) to 1,418 KRW (bull case); at 1,904 KRW, the current price sits above that range. The share trades about 42% below its 52-week high and 7% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 19% fair-value upside — at -40%, 115480 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 7, 2026. TTM = trailing twelve months.
About the company
CU Medical Systems, Inc. manufactures and sells defibrillators worldwide. The company offers automatic external defibrillators (AEDs), mechanical cardiopulmonary resuscitation systems, healthcare and rehabilitation products, AED trainers, and sterilizers/disinfectors. It also resells Apple products, including Mac, iPad, and iPod. The company was founded in 2001 and is headquartered in Wonju-si, South Korea.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
CU Medical Systems, Inc reported revenue of 48.2B KRW in FY2025 versus 35.4B KRW in FY2021, a compound +8.0%/yr. Reported net income was 819M KRW in FY2025.
Is 115480 fairly valued? → Check now
Similar stocks
10 more Healthcare Equipment & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 7, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| InBody Co 041830 | 44,450 KRW | 53,096 KRW | +19% |
| i-SENS, Inc 099190 | 15,280 KRW | 16,403 KRW | +7% |
| Value Added Technology Co 043150 | 19,080 KRW | 59,986 KRW | +214% |
| Mediana Co 041920 | 12,600 KRW | 13,550 KRW | +8% |
| Meta Biomed Co 059210 | 3,795 KRW | 9,374 KRW | +147% |
| Sewoon Medical Co 100700 | 2,120 KRW | 6,055 KRW | +186% |
| MEDIC MEDIC | 0.2000 PHP | 0.1300 PHP | -35% |
| MEKICS CO., Ltd 058110 | 2,015 KRW | 2,549 KRW | +27% |
| PeopleBio, Inc 304840 | 1,008 KRW | 401.44 KRW | -60% |
| NST NST | 0.6300 PLN | 0.2300 PLN | -63% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is CU Medical Systems, Inc (115480) undervalued?
What is the fair value of 115480?
What is the quality score of 115480?
What is the revenue of CU Medical Systems, Inc (115480)?
What is the net profit margin of 115480?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.